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Background: Viral meningitis is the most common form of aseptic meningitis and requires minimal investigation and treatment.
Polymerase chain reaction (PCR) has become the ‘gold standard’ for identifying viruses in cerebrospinal fluid and can provide
rapid results. The objective of the study was to describe the aetiology and epidemiology of viral meningitis at Tygerberg
Children’s Hospital, as well as the impact of a positive cerebral spinal fluid (CSF) viral panel on the duration of empiric
antibiotic treatment.
Methods: This was a retrospective folder review of all children aged between 29 days and 13 years who had a CSF specimen on
which a viral analysis was performed from January 1, 2010 to December 31, 2014.
Results: A total of 288 specimens were identified from the laboratory database. Seventy-nine specimens were presented for data
analysis. Thirty-seven specimens had a positive viral analysis. The median age was 11.3 months (IQR 3.7–49.16 months). The
microscopy and chemistry results were similar for the two groups except for the CSF lymphocyte count, which was
significantly higher in the group with a positive CSF viral analysis compared to those with a negative CSF viral analysis
(median 52 vs. 12 × 106/l, p = 0.005). The most common identified virus was Epstein–Barr virus (EBV) (23%), followed by
enterovirus (17%). Children with a positive viral analysis tended to receive antibiotics for longer than those who had
negative results (p = 0.223).
Conclusion: The addition of CSF viral analysis could be helpful in the management of children with meningitis, but at present
appears to have little impact on the length of antibiotic use.
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Background
Globally, preventable infectious diseases are a common cause of
morbidity and mortality. The major causes of death, namely diar-
rhoea and pneumonia, are well described.1 Meningitis, however,
is not as well described, but is estimated to be the cause in
between 3% and 4% of all deaths in children younger than 5
years of age.2
The early diagnosis of meningitis in infants and children is essen-
tial to prevent morbidity and mortality, but making a clinical
diagnosis can be difficult.3 Younger children often do not
present with the classical findings of neck stiffness as seen in
adults. In the absence of cerebrospinal fluid analysis a clear dis-
tinction cannot be made between viral and bacterial meningi-
tis.4 A delay in the initiation of antimicrobial therapy increases
the risk of morbidity and/or mortality. Guidelines, therefore,
advise that cases of suspected meningitis in infants and children
be started on empiric antibiotics as soon as possible. The anti-
biotic of choice is a third-generation cephalosporin (ceftriaxone
or cefotaxime) given for 5–7 days.3
Viral meningitis is the most common form of aseptic meningitis
and, with the exception of herpes simplex virus infection, is
usually benign and requires minimal investigation and treat-
ment. Viral meningitis is, however, historically difficult to diag-
nose and is also not routinely notified.5 Epidemiological data
are, therefore, not routinely available. Few studies in Africa
have reported identifying viruses from cerebrospinal fluid, but
those that did estimated viruses to be responsible for 14–25%
of all meningitis cases in Africa.2
The diagnosis of viral infections of the central nervous system
has improved with the advent of new molecular technologies.4
Polymerase chain reaction (PCR) has become the ‘gold standard’
for detection of viruses in cerebrospinal fluid.6 Application of
cerebrospinal fluid PCR has led to the identification of a viral
pathogen in 80–85% of cases of aseptic meningitis.7 Data,
however, are lacking on the clinical usefulness of viral PCR
results.8
Studies focusing on the impact of a positive molecular diagnosis
on clinical management are restricted to studies identifying
enteroviruses as cause of aseptic meningitis.7 These studies
demonstrated that prospective use of molecular tests on admis-
sion decreases the duration of antibiotic use.10 The use of rapid
enterovirus PCR reduced the duration of antibiotic use by a
median of 1.5 days (p < 0.001) in children admitted with sus-
pected meningitis.9
Though the benefits of rapid PCR diagnosis of enterovirus
meningitis are described, it is not clear what impact the diagno-
sis of non-enterovirus pathogens has on the clinical manage-
ment of patients.
Since 2010 the National Health Laboratory Service at Tygerberg
Hospital uses the Seeplex® Meningitis ACE detection kit for the
detection of viral pathogens in acute meningitis. This kit has
three components, two of which detect viruses. The Seeplex®
Meningitis V-1 detects six viruses: Herpes Simplex virus 1,
Herpes Simplex virus 2, Varicella-zoster virus, Epstein–Barr
virus, Cytomegalovirus, and Human Herpes Virus 6. The
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Seeplex® Meningitis V-2 component detects Human Entero-
virus.11 The virology department also has an in-house multiplex
for the detection of mumps and enterovirus. Specimens are pro-
cessed for viruses when requested as part of clinical care.
The aim of this study was to describe the aetiology and epide-
miology of viral meningitis in our hospital. We also aimed to
see whether a positive cerebrospinal fluid (CSF) viral panel
would have an effect on the length of antibiotic treatment.
This study was the first meningitis study conducted after the
introduction of the Seeplex® kit and the in-house multiplex for
the detection of mumps and enterovirus. It was also the first
study at the institution focusing solely on viral causes of menin-
gitis and its impact on clinical care.
Patients and methods
Setting
The study was conducted at Tygerberg Children’s Hospital in the
City of Cape Town, Western Cape, South Africa. The hospital has
direct access to the National Health Laboratory Service (NHLS)
Medical Virology laboratory where cerebrospinal fluid is pro-
cessed according to standard laboratory methods.
Design
All paediatric CSF specimens that had a viral analysis performed
between January 1, 2010 and December 31, 2014 were ident-
ified from the National Health Laboratory Service database. A
systematic query of the NHLS database was conducted to
ensure completeness of acquired data. After excluding CSF
specimens that did not meet the inclusion criteria mentioned
below, the patient records of the remaining patients were
requested from Tygerberg Hospital. A retrospective review of
patient records was done.
Ethics
Ethics approval was obtained from the Health Research Ethics
Committee at the University of Stellenbosch (S14/10/228).
Inclusion criteria
All children aged 29 days to 13 years of age admitted to Tyger-
berg Children’s Hospital with suspected meningitis between
January 1, 2010 and December 31, 2014 and who had a cere-
brospinal fluid viral analysis performed were included in the
study. Those with CSF results which were normal (lymphocytes
< 6 × 106/l and neutrophils < 1 × 106/l), traumatic (erythrocytes
> 10 000 × 106/l), positive for bacteria or Cryptococcus on
microscopy or culture, Cepheid® GeneXpert MTB/Rif or CLAT
positive or processed outside of the National Health Laboratory
Service at Tygerberg Hospital were excluded from the analysis.
Children referred to step-down facilities for completion of treat-
ment were also excluded.
Patients admitted to the intensive care units were excluded as
these ill children usually have co-morbid factors or other infec-
tions that could influence the length of antibiotic use, irrespec-
tive of the results of a CSF viral analysis. It was also not possible
to evaluate the duration of antibiotic use in children referred to
step-down facilities as the researcher did not have access to
clinical records in these facilities.
Statistical analysis
The data were organised in an Excel spreadsheet (Microsoft
Corp, Redmond, WA, USA) for the purposes of statistical analysis.
Data were analysed using STATA version 13 (StataCorp 2013.
College Station, TX, USA). A p-value of < 0.05 was considered
significant. Categorical variables were described using frequen-
cies and percentages. Quantitative data were described using
median and interquartile range (IQR). The relationship
between HIV status and viral analysis result was described
using Fisher’s exact test, while the relationship between viral
analysis result and duration of antibiotic use, and the relation-
ship between HIV status and duration of antibiotic use were ana-
lysed using the Mann–Whitney U-test.
Results
Two hundred and eighty-eight culture-negative specimens that
had a CSF viral analysis performed were identified. After exclu-
sion for duplicate patient specimens, traumatic taps, normal
CSF, incomplete data and remaining neonates, a total of 79
patients remained for data analysis (Figure 1). There were 36
specimens positive on viral PCR. The most common was EBV
with 18 specimens, 8 were herpes viral panel positive, 9 entero-
virus positive and 5 with dual infection (Table 1). After further
review of the specimens, those that were positive for Epstein–
Barr virus only were also excluded from the analysis. Thus 19
specimens remained positive and were included in the analysis.
Forty-two specimens were negative (Table 2). The male:female
ratio was 1.65:1. The median age was 11.3 months (IQR 3.7–
49.16 months). Antibiotics were started in 87% of cases (53/
61). Ceftriaxone was the most commonly used in 42% of cases
(22/53). Empiric acyclovir was started in one case (negative
viral panel analysis). Anti-tuberculosis treatment was started
together with antibiotics in 30% of cases (18/61) and conse-
quently stopped again in 10 of the 18 cases; in the remainder
Figure 1: Flow diagram showing selection of specimens for inclusion in
the study.
102 Southern African Journal of Infectious Diseases 2018; 33(4):101–105
of cases the anti-tuberculosis treatment was continued. A CSF
cell count and chemistry was performed in all cases. The
median polymorph nuclear (PMN) cell count was 2 × 106/l (IQR:
0–19 x106/l) and the median CSF lymphocyte count was 20 ×
106/l (IQR: 6–69 x106/l). The median CSF protein level was
0.41 g/l (IQR 0.31–0.65 g/l). The median CSF glucose was
3.4 mmol/l (IQR 2.9–4 mmol/l). The median duration of antibiotic
use was 4 days (IQR: 1–5 days).
There was a trend that children with a positive CSF viral analysis
were younger than the children with a negative CSF viral analy-
sis (median 8.8 months vs. 13.8 months). This was, however, not
significant (p = 0.60). The microscopy and chemistry results were
similar for the two groups except for the CSF lymphocyte count,
which was significantly higher in the group with a positive CSF
viral analysis compared with those with a negative CSF viral
analysis (median 52 vs. 12 × 106/l, p = 0.005) (Figure 2). The
glucose for both groups fell within the normal range (median
value 3.4 vs. 3.35 mmol/l, p = 0.76), the median protein was
normal in the negative CSF group and only slightly raised in
the positive group (0.37 g/l vs. 0.43 g/l, p = 0.45).
A larger proportion of children with a negative CSF viral panel
analysis (16% vs. 5% in viral panel positive patients) were
never started on antibiotics. Children with a positive viral analy-
sis received antibiotics for longer than those that had a negative
result (median 5 days; IQR 2–5 days vs 2.5 days; IQR 1–5 days);
however, this was not significant (p = 0.223).
The HIV status was unknown in 61% of cases (37/61), negative in
31% of cases (19/61) and positive in 7% of cases (4/61) (Figure 3).
Of those who were HIV infected, 71% (5/7) were already receiv-
ing antiretroviral therapy. There was no relationship between
HIV status and viral panel analysis result (p = 0.886).
Discussion
This study presents the information on viral meningitis in the
paediatric population at Tygerberg Children’s Hospital,
Western Cape, South Africa for a five-year period from January
1, 2010 to December 31, 2014. This coincides with the period
when the Seeplex® kit for CSF viral analysis became available
at the institution.
Enterovirus is well known as the most common cause of viral
meningitis in childhood and is best described in the literature.6
A study in Cape Town, South Africa isolated viruses in 3 406 of
the 11 360 specimens; 91% yielded enteroviruses.5 This was
also reflected in our study. A large proportion of specimens in
our study yielded EBV as an isolate. EBV genetic material can,
Table 1: Aetiology of viral meningitis
Isolate Number % of total isolates
Negative 42 53%
Epstein–Barr virus 18 24%
Enterovirus 9 11%
Herpes simplex virus 1 1%
HHV-6 4 4%
Dual infection 5 6%
Total 79
Table 2: Epidemiology of viral meningitis
CSF viral
analysis
positive (EBV
excluded)
CSF viral
analysis
negative
All
specimens
n 19 42 61
Male:female
ratio
2.8 :1 1.33:1 1.65: 1
Age (median) 8.8 months 13.8 months 11.3
months
Median PMN
count
3 × 106/l 1 × 106/l 2 × 106/l
Median
lymphocyte
count
52 × 106/l 12 × 106/l 20 × 106/l
Median protein
level
0.43 g/l 0.37 g/l 0.41 g/l
Median glucose
level
3.4 mmol/l 3.35 mmol/l 3.4 mmol/l
Median
duration of
antibiotic use
5 days 2.5 days 4 days
Figure 3: HIV status during admission.
Figure 2: Box plot of CSF lymphocyte cell count distribution for positive
and negative viral panels.
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however, be carried in lymphocytes after a primary infection.
When the lymphocytes cross the blood–brain barrier, this
genetic material will be present in the lymphocytes in the CSF.
This EBV genetic material can, therefore, be picked up by the
viral panel assay without there being active infection.12 EBV
was, therefore, excluded from the analysis. Although the same
can be true for HHV-6, it was felt that HHV-6 can be associated
with symptoms of meningitis as well as febrile seizures in
infants (a common reason for lumbar puncture in the emer-
gency care setting) and was, therefore, included in the analysis.
Viral PCR results should, therefore, always be interpreted in con-
junction with the clinical history as viral DNA may easily be
picked up by PCR in the presence of lymphocytes.
CSF parameters in cases with a positive CSF viral analysis were
similar to those with a negative viral analysis, except for lympho-
cyte count, which was significantly higher in positive cases (p =
0.005). This is to be expected as viral meningitis typically has a
CSF with raised lymphocytes but normal protein and glucose
values.
Our study showed a male predominance among those with a
positive CSF viral panel analysis. This is in keeping with the find-
ings of an earlier study in Cape Town.5 Even though the study
excluded neonates from the analysis, the median age among
those with a positive CSF viral panel analysis remains relatively
low (8.8 months). This most likely reflects the young population
which is seen in our casualty and short-stay ward.13
Some 61% (37/61) of cases with meningitis did not have an HIV
status documented, thus the number of HIV infected cases was
small and it was, therefore, difficult to draw inferences with regard
to the epidemiology of viral meningitis in HIV infected children.
A large proportion of children in this study (18/61; 30%) were
started on concomitant TB treatment. Even though the anti-tuber-
culous treatment was stopped in some cases, 40% of cases were
dischargedwithanti-tuberculous treatmentand thus thediagnosis
of tuberculousmeningitis. This reflects thehighburdenof tubercu-
losis in theWestern Cape, with TBM being themost common form
of bacterial meningitis in the area.14
The literature suggests that a positive viral analysis of the CSF
leads to shorter duration of antibiotic use (2.3 days shorter).6
We, however found the opposite to this, where children with a
positive viral panel analysis had a median duration of antibiotic
use of 5 days, compared with those with a negative viral panel
analysis receiving a median duration of 2.5 days of antibiotics.
This, however, was not a statistically significant finding (p =
0.223). Reasons for this longer duration may include longer turn-
around times as at the time of the study, that PCRs were not pro-
cessed as a 24 hour service, delayed identification of the result
by clinicians as results are documented on an online service
and are not phoned out, and that the initial rollout of the
service was limited to Mondays, Wednesdays and Fridays, thus
earlier specimens had a longer turnaround time. We were also
unable to ascertain the clinical reason for stopping antibiotics
as this was poorly documented in the patient folders, thus the
reason for continuing or stopping antibiotics may have been
unrelated to the PCR result.
Study limitations
There are a number of limitations to this study. This includes a
small sample size. This is a retrospective folder review and the
data quality was dependent on the availability, accessibility
and quality of data kept. The study utilised consecutive
sampling, including all children that meet the inclusion criteria.
This could have introduced bias into the study, but there is no
reason to believe that children are not admitted in a random
way. The study was conducted at a single centre. Since Tyger-
berg Children’s Hospital is a large referral centre, children with
mild or moderate disease might be underrepresented in this
study as they receive treatment at their local level 1 or level 2
health facilities.
Recommendations
Ongoing viral meningitis surveillance is necessary to present a
clear picture on viral meningitis in childhood. A prospective
study should be conducted to include clinical data, as well as
data on length of stay and potential hospital cost saved due
to the addition of CSF viral analysis to clinical care. Such a
study design could also include the neonatal age group.
Conclusion
The addition of CSF viral analysis may be helpful in the manage-
ment of children with meningitis, but at present appears to have
little impact on the use of empiric antibiotics in Tygerberg Chil-
dren’s Hospital.
Disclosure statement – No potential conflict of interest was
reported by the authors.
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